Correlation Between AN2 Therapeutics and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Salarius Pharmaceuticals, you can compare the effects of market volatilities on AN2 Therapeutics and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Salarius Pharmaceuticals.
Diversification Opportunities for AN2 Therapeutics and Salarius Pharmaceuticals
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Salarius is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Salarius Pharmaceuticals
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 0.67 times more return on investment than Salarius Pharmaceuticals. However, AN2 Therapeutics is 1.49 times less risky than Salarius Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 110.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would earn a total of 27.00 from holding AN2 Therapeutics or generate 24.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| AN2 Therapeutics |
| Salarius Pharmaceuticals |
AN2 Therapeutics and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Salarius Pharmaceuticals
The main advantage of trading using opposite AN2 Therapeutics and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets |